tiprankstipranks
Trending News
More News >
Plus Therapeutics (PSTV)
NASDAQ:PSTV
US Market

Plus Therapeutics (PSTV) Financial Statements

Compare
1,598 Followers

Plus Therapeutics Financial Overview

Plus Therapeutics's market cap is currently $80.41M. The company's EPS TTM is $-0.04; its P/E ratio is -0.31; Plus Therapeutics is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 5.82M$ 4.91M$ 224.00K$ 0.00$ 303.00K
Gross Profit$ 4.97M$ -4.78M$ -488.00K$ -66.00K$ -2.40M
Operating Income$ -14.70M$ -13.32M$ -19.71M$ -12.49M$ -9.58M
EBITDA$ -8.40M$ -12.69M$ -18.85M$ -12.05M$ -8.44M
Net Income$ -12.98M$ -13.32M$ -20.27M$ -13.40M$ -8.24M
Balance Sheet
Cash & Short-Term Investments$ 3.61M$ 8.55M$ 18.12M$ 18.40M$ 8.35M
Total Assets$ 6.63M$ 11.39M$ 23.87M$ 21.98M$ 12.11M
Total Debt$ 3.37M$ 4.18M$ 5.75M$ 6.99M$ 7.00M
Net Debt$ 3.29M$ -4.37M$ -12.37M$ -11.41M$ -1.35M
Total Liabilities$ 15.58M$ 12.74M$ 17.42M$ 11.14M$ 9.07M
Stockholders' Equity$ -8.95M$ -1.35M$ 6.45M$ 10.84M$ 3.03M
Cash Flow
Free Cash Flow$ -10.70M$ -13.01M$ -13.73M$ -10.42M$ -8.93M
Operating Cash Flow$ -10.55M$ -12.85M$ -12.97M$ -10.28M$ -8.43M
Investing Cash Flow$ -4.11M$ -160.00K$ -759.00K$ -82.00K$ -493.00K
Financing Cash Flow$ 6.19M$ 3.44M$ 13.45M$ 20.42M$ -319.00K
Currency in USD

Plus Therapeutics Earnings and Revenue History

Plus Therapeutics Debt to Assets

Plus Therapeutics Cash Flow

Plus Therapeutics Forecast EPS vs Actual EPS